Naringin as a beneficial natural product against degeneration of the nigrostriatal dopaminergic projection in the adult brain

Naringin as a beneficial natural product against degeneration of the nigrostriatal dopaminergic projection in the adult brain

Bibliographic Details
Main Author:	Sang Ryong Kim
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2017-01-01
Series:	Neural Regeneration Research
Online Access:	http://www.nrronline.org/article.asp?issn=1673-5374;year=2017;volume=12;issue=8;spage=1375;epage=1376;aulast=Kim

Similar Items

Clinical Features Indicating Nigrostriatal Dopaminergic Degeneration in Drug-Induced Parkinsonism
by: Seung Ha Lee, et al.
Published: (2017-01-01)

Astrocytes and retrograde degeneration of nigrostriatal dopaminergic neurons in Parkinson’s disease: removing axonal debris
by: Ingrid Morales, et al.
Published: (2021-11-01)

Pathological remodelling of colonic wall following dopaminergic nigrostriatal neurodegeneration
by: Carolina Pellegrini, et al.
Published: (2020-06-01)

Dopaminergic denervation and associated MRI microstructural changes in the nigrostriatal projection in early Parkinson’s disease patients
by: M. López-Aguirre, et al.
Published: (2023-10-01)

MRI Findings in Parkinson’s Disease: Radiologic Assessment of Nigrostriatal Degeneration
by: Yun Jung Bae, et al.
Published: (2022-05-01)

Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice
by: Wang Qingshan, et al.
Published: (2012-06-01)

Two distinct degenerative types of nigrostriatal dopaminergic neuron in the early stage of parkinsonian disorders
by: Tomoya Kawazoe, et al.
Published: (2024-01-01)

Nigrostriatal degeneration determines dynamics of glial inflammatory and phagocytic activity
by: Leyre Ayerra, et al.
Published: (2024-04-01)

Beneficial role of naringin against methotrexate-induced injury to rat testes: biochemical and ultrastructural analyses
by: Hany Elsawy, et al.
Published: (2022-12-01)

Dopamine Synthesis in the Nigrostriatal Dopaminergic System in Patients at Risk of Developing Parkinson’s Disease at the Prodromal Stage
by: Victor Blokhin, et al.
Published: (2024-02-01)

GDNF Overexpression from the Native Locus Reveals its Role in the Nigrostriatal Dopaminergic System Function.
by: Anmol Kumar, et al.
Published: (2015-12-01)

Inter-hemispheric asymmetry of nigrostriatal dopaminergic lesion. A possible compensatory mechanism in Parkinson’s disease
by: Javier eBlesa, et al.
Published: (2011-11-01)

Neonatal exposure to lipopolysaccharide enhances vulnerability of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life
by: Lir-Wan Fan, et al.
Published: (2011-12-01)

The Age of Striatum Determines the Pattern and Extent of Dopaminergic Innervation: a Nigrostriatal Double Graft Study
by: Ingrid Stromberg, et al.
Published: (1997-05-01)

Characterization of substantia nigra neurogenesis in homeostasis and dopaminergic degeneration: beneficial effects of the microneurotrophin BNN-20
by: Theodora Mourtzi, et al.
Published: (2021-06-01)

Modeling of the Progressive Degradation of the Nigrostriatal Dopaminergic System in Mice to Study the Mechanisms of Neurodegeneration and Neuroplasticity in Parkinson’s Disease
by: Anna Kolacheva, et al.
Published: (2022-12-01)

Functional connectivity of the cortico-subcortical sensorimotor loop is modulated by the severity of nigrostriatal dopaminergic denervation in Parkinson’s Disease
by: Mario Quarantelli, et al.
Published: (2022-09-01)

Correction: GDNF Overexpression from the Native Locus Reveals its Role in the Nigrostriatal Dopaminergic System Function.
by: Anmol Kumar, et al.
Published: (2016-01-01)

Nigrostriatal Dopaminergic Dysfunction and Altered Functional Connectivity in REM Sleep Behavior Disorder With Mild Motor Impairment
by: Gohei Yamada, et al.
Published: (2019-07-01)

Iron Chelators and Antioxidants Regenerate Neuritic Tree and Nigrostriatal Fibers of MPP+/MPTP-Lesioned Dopaminergic Neurons.
by: Pabla Aguirre, et al.
Published: (2015-01-01)

Potential Beneficial Effects of Naringin and Naringenin on Long COVID—A Review of the Literature
by: Siqi Liu, et al.
Published: (2024-02-01)

Premorbid performances determine the deleterious effects of nigrostriatal degeneration and pramipexole on behavioural flexibility
by: Mélina Decourt, et al.
Published: (2023-03-01)

Neuroprotective effects of GSK-343 in an in vivo model of MPTP-induced nigrostriatal degeneration
by: Deborah Mannino, et al.
Published: (2023-06-01)

Metformin Prevents Nigrostriatal Dopamine Degeneration Independent of AMPK Activation in Dopamine Neurons.
by: Jacqueline A Bayliss, et al.
Published: (2016-01-01)

Beneficial effects of AAV1-Rheb(S16H) administration in the adult hippocampus
by: Sang Ryong Kim
Published: (2020-01-01)

Degeneration of the nigrostriatal pathway and induction of motor deficit by tetrahydrobiopterin: an in vivo model relevant to Parkinson’s disease
by: Seong Who Kim, et al.
Published: (2003-07-01)

GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson’s disease
by: Xavier ed'Anglemont De Tassigny, et al.
Published: (2015-02-01)

Distinct Connectivity and Functionality of Aldehyde Dehydrogenase 1a1-Positive Nigrostriatal Dopaminergic Neurons in Motor Learning
by: Junbing Wu, et al.
Published: (2019-07-01)

miR‐30b protects nigrostriatal dopaminergic neurons from MPP(+)‐induced neurotoxicity via SNCA
by: Yu‐fei Shen, et al.
Published: (2020-04-01)

Function and Regulation of ALDH1A1-Positive Nigrostriatal Dopaminergic Neurons in Motor Control and Parkinson’s Disease
by: Kathleen Carmichael, et al.
Published: (2021-05-01)

1-Methyl-4-phenylpyridinium stereotactic infusion completely and specifically ablated the nigrostriatal dopaminergic pathway in rhesus macaque.
by: Xiaoguang Lei, et al.
Published: (2015-01-01)

Ectopic pregnancy-derived human trophoblastic stem cells regenerate dopaminergic nigrostriatal pathway to treat parkinsonian rats.
by: Tony Tung-Yin Lee, et al.
Published: (2012-01-01)

GABAergic Control of Nigrostriatal and Mesolimbic Dopamine in the Rat Brain
by: Susanne Nikolaus, et al.
Published: (2018-03-01)

Striatal injection of 6-hydroxydopamine induces retrograde degeneration and glial activation in the nigrostriatal pathway
by: Ricardo Wilson Pinho Rodrigues, et al.
Published: (2003-08-01)

Metabolic Covariant Network in relation to Nigrostriatal Degeneration in Carbon Monoxide Intoxication-related Parkinsonism
by: Chiung-Chih eChang, et al.
Published: (2016-05-01)

Correction: 1-Methyl-4-Phenylpyridinium Stereotactic Infusion Completely and Specifically Ablated the Nigrostriatal Dopaminergic Pathway in Rhesus Macaque.
by: Xiaoguang Lei, et al.
Published: (2016-01-01)

Retraction: Ectopic Pregnancy-Derived Human Trophoblastic Stem Cells Regenerate Dopaminergic Nigrostriatal Pathway to Treat Parkinsonian Rats.
by: PLOS ONE Editors
Published: (2021-01-01)

Activation of Antioxidant and Proteolytic Pathways in the Nigrostriatal Dopaminergic System After 3,4-Methylenedioxymethamphetamine Administration: Sex-Related Differences
by: Giulia Costa, et al.
Published: (2021-08-01)

Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease
by: Ulrika Nordström, et al.
Published: (2015-01-01)

Microglia-Derived Cytokines/Chemokines Are Involved in the Enhancement of LPS-Induced Loss of Nigrostriatal Dopaminergic Neurons in DJ-1 Knockout Mice.
by: Chia-Hung Chien, et al.
Published: (2016-01-01)